Vanderbilt University is requesting funds for an Extracellular Flux Analyzer. Faculty in the School of Medicine and in the School of Engineering will use this instrument. Vanderbilt does not possess an Analyzer or equivalent instrumentation. The Analyzer allows the non-invasive real-time study of cellular bioenergetics in adherent or suspension cells, permeabilized cells, isolated mitochondria or whole organisms. To improve data reproducibility a companion Prep Station that contains an integrated media exchanger and non-CO2 incubator is also requested. Participating investigators study numerous disease states in which metabolic dysfunction has been implicated such as cancer, obesity and neurodegenerative disorders. In order to facilitate their PHS-funded studies it is essential that the ability to easily evaluate energy requirements in a variety of biological samples be available. The Analyzer is a widely accepted platform for the study of metabolism. There are seven major users and three minor users. The Analyzer will be maintained and administered by the Vanderbilt High Throughput Screening (VHTS) facility. The VHTS has expertise in plate-based, multi-condition interrogation of biological phenomena. The VHTS is an essential and highly successful facility and is maintained by financial support from Vanderbilt. In summary, the Analyzer will dramatically enhance current and future research in bioenergetics at Vanderbilt.

Agency
National Institute of Health (NIH)
Institute
Office of The Director, National Institutes of Health (OD)
Type
Biomedical Research Support Shared Instrumentation Grants (S10)
Project #
1S10OD018015-01
Application #
8639912
Study Section
Special Emphasis Panel (ZRG1-IMST-R (30))
Program Officer
Birken, Steven
Project Start
2014-09-27
Project End
2015-09-26
Budget Start
2014-09-27
Budget End
2015-09-26
Support Year
1
Fiscal Year
2014
Total Cost
$199,617
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Pathology
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Fensterheim, Benjamin A; Young, Jamey D; Luan, Liming et al. (2018) The TLR4 Agonist Monophosphoryl Lipid A Drives Broad Resistance to Infection via Dynamic Reprogramming of Macrophage Metabolism. J Immunol 200:3777-3789
Raybuck, Ariel L; Cho, Sung Hoon; Li, Jingxin et al. (2018) B Cell-Intrinsic mTORC1 Promotes Germinal Center-Defining Transcription Factor Gene Expression, Somatic Hypermutation, and Memory B Cell Generation in Humoral Immunity. J Immunol 200:2627-2639
Chen, Xinping; Austin, Eric D; Talati, Megha et al. (2017) Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects. Eur Respir J 50:
Egnatchik, Robert A; Brittain, Evan L; Shah, Amy T et al. (2017) Dysfunctional BMPR2 signaling drives an abnormal endothelial requirement for glutamine in pulmonary arterial hypertension. Pulm Circ 7:186-199
Hardeman, Keisha N; Peng, Chengwei; Paudel, Bishal B et al. (2017) Dependence On Glycolysis Sensitizes BRAF-mutated Melanomas For Increased Response To Targeted BRAF Inhibition. Sci Rep 7:42604
Lee, Kyung-Min; Giltnane, Jennifer M; Balko, Justin M et al. (2017) MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation. Cell Metab 26:633-647.e7